NANOCHON

Washington, United States

Nanochon develops medical implant technology focused on cartilage repair for patients with joint surface damage.

$4.1M raised

Jan 2026

Seed

3D Printing Biotechnology Medical Device

Top Investors

Alumni VenturesNational Science FoundationCreative Destruction Lab (CDL)cultivate(MD)Wilson Sonsini Goodrich & Rosati

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about NANOCHON

How much funding has NANOCHON raised?

NANOCHON has raised $4.1M in total funding. The most recent round was Seed. The last funding was announced in January 2026.

Who are NANOCHON's investors?

NANOCHON's investors include Alumni Ventures, National Science Foundation, Creative Destruction Lab (CDL), cultivate(MD), Wilson Sonsini Goodrich & Rosati.

Where is NANOCHON headquartered?

NANOCHON is headquartered in Washington, United States.

What does NANOCHON do?

Nanochon develops medical implant technology focused on cartilage repair for patients with joint surface damage.

What stage is NANOCHON at?

NANOCHON is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 12, 2026.

MLA

"NANOCHON — Funding & Investors." VCBacked, January 12, 2026, https://www.vcbacked.co/company/nanochon. Accessed June 3, 2026.

APA

VCBacked. (2026). NANOCHON — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/nanochon

Wikipedia (cite web)

{{cite web |title=NANOCHON — Funding & Investors |url=https://www.vcbacked.co/company/nanochon |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 12, 2026.

Similar Companies in 3D Printing